New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.

MLA

Rosière, Rémi, et al. “New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.” Molecular Pharmaceutics, vol. 15, no. 3, Mar. 2018, pp. 899–910. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.7b00846.

APA

Rosière, R., Van Woensel, M., Gelbcke, M., Mathieu, V., Hecq, J., Mathivet, T., Vermeersch, M., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2018). New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. Molecular Pharmaceutics, 15(3), 899–910. https://doi.org/10.1021/acs.molpharmaceut.7b00846

Chicago

Rosière, Rémi, Matthias Van Woensel, Michel Gelbcke, Véronique Mathieu, Julien Hecq, Thomas Mathivet, Marjorie Vermeersch, Pierre Van Antwerpen, Karim Amighi, and Nathalie Wauthoz. 2018. “New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.” Molecular Pharmaceutics 15 (3): 899–910. doi:10.1021/acs.molpharmaceut.7b00846.